Crossref
Durable Response To Capecitabine (Xeloda; Roche) In An Elderly Patient With Liver And Bone Metastases Of Breast Cancer
The Internet Journal of Oncology · 2006
DOI: 10.5580/1752 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Internet Journal of Oncology, 2006.
Abstract (Originalsprache)
This case report concerns an elderly patient with liver and bone metastases of breast cancer successfully treated for two-years with capecitabine as first line chemotherapy without any side effect.
Zitieren
APA
(2006). Durable Response To Capecitabine (Xeloda; Roche) In An Elderly Patient With Liver And Bone Metastases Of Breast Cancer. The Internet Journal of Oncology. https://doi.org/10.5580/1752
Vancouver
Durable Response To Capecitabine (Xeloda; Roche) In An Elderly Patient With Liver And Bone Metastases Of Breast Cancer. The Internet Journal of Oncology. 2006. doi:10.5580/1752
BibTeX
@article{euvimed2006,
title = {Durable Response To Capecitabine (Xeloda; Roche) In An Elderly Patient With Liver And Bone Metastases Of Breast Cancer},
journal = {The Internet Journal of Oncology},
year = {2006},
doi = {10.5580/1752}
}
EUVIMED